# Agios Pharmaceuticals, Inc. (AGIO): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/agio for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is developing AG-946, which is currently undergoing Phase I clinical studies for treating hemolytic anemias and other diseases. Established in 2007, the company's main office is located in...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $37.00 USD |
| Market Cap | $2.21B |
| P/E (TTM) | — |
| EPS (TTM) | −$7.01 |
| 52-Week Range | $22.24 – $46.00 |
| Dividend Yield (TTM) | — |

## Dividend

AGIO has no dividend payment history in our records.

## Frequently Asked Questions

### What does Agios Pharmaceuticals, Inc. do?

Agios Pharmaceuticals, Inc. (AGIO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is AGIO's market cap?

Agios Pharmaceuticals, Inc. (AGIO) has a market capitalization of approximately $2.21 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does AGIO pay a dividend?

No, Agios Pharmaceuticals, Inc. (AGIO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is AGIO profitable?

Agios Pharmaceuticals, Inc. (AGIO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has AGIO ever paid a dividend?

No. Dividend Data's records show no dividend payments from Agios Pharmaceuticals, Inc. (AGIO). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/agio
- Dividend history & safety: https://www.dividenddata.com/stocks/agio/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/agio/earnings
- Financial statements: https://www.dividenddata.com/stocks/agio/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/agio/valuation
- Peer comparison: https://www.dividenddata.com/stocks/agio/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.